Take the Direct Route to Commercialization in Canada
Why Canada: Is Canada an attractive market for global pharmaceutical manufacturers?
In addition to being among the top 10 pharmaceutical markets in the world, Sandra Anderson, Senior Vice President, Commercialization and Strategy, discusses why the Canadian pharmaceutical sector has a growing presence and what makes it so attractive to manufacturers.
Why Canada: How we help Pharmaceutical Manufacturers commercialize their products in Canada.
Not only does Innomar Strategies provide strategic advice and planning, but we also execute and implement all end-to-end commercialization services for companies launching a new therapy into the Canadian marketplace.
Protecting Temperature-Sensitive Pharmaceuticals, Without Unnecessary Plastic Waste
March 24th 2025Advances in the life sciences are driving a significant increase in the number of temperature-sensitive pharmaceuticals. The packaging industry is meeting the moment with advances of its own, including high-performance, environmentally-friendly materials that allow life science companies meet stringent thermal requirements and ambitious CO2e reduction goals. In this episode, TemperPack’s CEO Peter Wells shares insights from working with life sciences to move to certified biobased, home compostable, and curbside recyclable shipping solutions.
